A Delaware overview of physician-supervised GLP-1 treatment through Astra, including local access context and the cities we cover. Every statistic on this page links to its source.
36.6% of Delaware adults have obesity, per the CDC's 2024 BRFSS prevalence estimates 1. In Wilmington, the state's largest city, CDC PLACES puts adult obesity at 41.0% 2, well above the statewide figure.
Delaware is also one of the few states where the Medicaid answer is yes rather than no, which changes what the rest of this page is about.
Delaware's fee-for-service Medicaid program covers GLP-1 medications for obesity treatment, one of just 13 state Medicaid programs doing so per KFF's national tracker 78. Delaware carries no partial-coverage or funding-limit footnote in that tracker, unlike several neighboring states 8.
One honest caveat. Delaware delivers most Medicaid care through managed-care organizations under the Diamond State Health Plan, and those individual formularies and prior-authorization criteria were not independently verified against the state's own Preferred Drug List: Delaware's DHSS/DMMA site blocked automated research access during this review. Treat the fee-for-service coverage finding as solid and third-party-sourced, and treat drug-specific and MCO-level mechanics as unconfirmed until you check with your plan.
If you are a Diamond State Health Plan member, the practical next step is to ask your MCO for its weight-management prior-authorization criteria in writing.
Medicaid coverage does not reach everyone. Delaware's uninsured rate is 6.9% and median household income is $87,534 (ACS 2024 1-year estimates) 6, so a meaningful share of the state's 1,051,917 residents 34 are paying cash for anything a commercial plan excludes.
Astra's price in Delaware is the same as everywhere else we operate: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans ($816 and $1,416 billed annually), the same price at every dose. There is no Delaware-specific price or discount.
TODO — not yet verified. Delaware's telehealth-prescribing rules were out of scope for this research pass, which covered Medicaid status, obesity, population, and income only. This page does not assert a Delaware-specific rule; confirm current requirements with the Delaware Board of Medical Licensure and Discipline.
Astra serves patients in all 50 states, Delaware included. Visits and refills happen online, and medication ships from a state-licensed US compounding pharmacy.
Wilmington, where adult obesity runs 4.4 points above the state rate 12, has its own page below.
Astra treats patients in Delaware through state-licensed physicians.
City-level detail for Delaware.
Yes — Delaware's fee-for-service Medicaid program covers GLP-1 medications for obesity treatment, one of only 13 state Medicaid programs that do, per KFF's tracker of state Medicaid GLP-1 policy. Delaware delivers most Medicaid coverage through managed-care plans, so exact drug lists and prior-authorization steps can vary by plan — check with your specific plan for details.
No. Astra charges the same nationwide: $68/mo for semaglutide and $118/mo for tirzepatide, both on 12-month plans billed annually ($816 and $1,416 total). Delaware residents pay the identical price as patients in every other state — Astra does not adjust pricing by location.
Astra's plans run $68/mo for semaglutide or $118/mo for tirzepatide, billed as a 12-month plan ($816 or $1,416 total). That's the same price structure in Delaware as everywhere else Astra operates.
Astra is licensed to provide care in all 50 states, including every city and county in Delaware — Wilmington, Dover, Newark, and beyond. Care is delivered entirely online, so location within the state doesn't affect access.
Telehealth prescribing is broadly permitted in Delaware, and Astra's clinicians follow Delaware's standard-of-care requirements for every patient. [TODO: this answer needs a specific citation to the Delaware Board of Medical Licensure and Discipline's telehealth/remote-prescribing rule — not yet verified; see telehealthRules.todo above.]
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.